Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piret Viiklepp

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Indian Journal of Tuberculosis|March 20, 2014
Long-term follow-up after thoracoscopic resection of solitary pulmonary tuberculomaTanel Laisaar, Piret Viiklepp, Vahur Hollo
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal contextAnna Vyazovaya, Klavdia Levina, Viacheslav Zhuravlev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
Reply to van Deun and DecrooJ Peter Cegielski, Zarir F Udwadia, Piret Viiklepp, et al.
Biometrics|December 24, 2019
Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysisGuanbo Wang, Mireille E Schnitzer, Dick Menzies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Reply to van Deun and DecrooJ P Peter Cegielski, Zarir F Udwadia, Piret Viiklepp, et al.
Transboundary and Emerging Diseases|August 2, 2020
Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority countryIgor Mokrousov, Anna Vyazovaya, Klavdia Levina, et al.
BMC Medical Research Methodology|November 24, 2021
Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysisFatema Tuj Johara, Andrea Benedetti, Robert Platt, et al.
The European Respiratory Journal|January 4, 2017
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysisGreg J Fox, Andrea Benedetti, Helen Cox, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2021
A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosisKadri Klaos, Anna Agejeva, Tiina Kummik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2020
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016J Peter Cegielski, Pei-Chun Chan, Zhiyi Lan, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Indian Journal of Tuberculosis|March 20, 2014
Long-term follow-up after thoracoscopic resection of solitary pulmonary tuberculomaTanel Laisaar, Piret Viiklepp, Vahur Hollo
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal contextAnna Vyazovaya, Klavdia Levina, Viacheslav Zhuravlev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
Reply to van Deun and DecrooJ Peter Cegielski, Zarir F Udwadia, Piret Viiklepp, et al.
Biometrics|December 24, 2019
Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysisGuanbo Wang, Mireille E Schnitzer, Dick Menzies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2022
Correction to: Reply to van Deun and DecrooJ P Peter Cegielski, Zarir F Udwadia, Piret Viiklepp, et al.
Transboundary and Emerging Diseases|August 2, 2020
Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority countryIgor Mokrousov, Anna Vyazovaya, Klavdia Levina, et al.
BMC Medical Research Methodology|November 24, 2021
Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysisFatema Tuj Johara, Andrea Benedetti, Robert Platt, et al.
The European Respiratory Journal|January 4, 2017
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysisGreg J Fox, Andrea Benedetti, Helen Cox, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2021
A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosisKadri Klaos, Anna Agejeva, Tiina Kummik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2020
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016J Peter Cegielski, Pei-Chun Chan, Zhiyi Lan, et al.
Pageof 4